Literature DB >> 31411983

Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy.

Yuval Freifeld1, Solomon L Woldu1, Nirmish Singla1, Timothy Clinton1, Aditya Bagrodia1, Ryan Hutchinson1, Yair Lotan1, Vitaly Margulis2.   

Abstract

BACKGROUND: Radical nephrectomy with inferior vena cava thrombectomy (RN-IVCT) is a complicated procedure for which the impact of hospital case volume on overall survival (OS) is unknown.
OBJECTIVE: To assess the degree to which renal cell carcinoma (RCC) with inferior vena cava tumor thrombus (IVC-TT) care is centralized and to evaluate the impact of hospital case volume on outcomes following RN-IVCT. DESIGN, SETTING, AND PARTICIPANTS: The National Cancer Data Base was queried for patients with pT3b-c RCC treated with RN-IVCT. Hospitals were classified by case volume percentile as low (<75th percentile, <0.67 cases annually), intermediate (75th-95th percentile, 0.67-2.99 cases annually), or high (>95th percentile, >3 cases annually). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was OS. Secondary outcomes were short-term (30- and 90-d) mortality rates according to hospital case volume. Kaplan-Meier curves and Cox regression model were used to evaluate OS and the effect of covariables. RESULTS AND LIMITATIONS: There were 2664 cases of RN-IVCT for pT3b-c tumors reported by 573 institutions, of which 435, 108, and 30 were classified as low, intermediate, and high volume, accounting for 28.5%, 34.5%, and 37% of cases, respectively. Treatment at high-volume institutions was associated with better OS: the median OS was 42, 53, and 60 months for low, intermediate and high-volume centers, respectively (p=0.009). After multivariable adjustment, treatment at a high-volume institution was associated with a 24% relative risk reduction for all-cause mortality compared to treatment at a low-volume institution (hazard ratio 0.76, 95% confidence interval 0.65-0.89; p=0.001). There was no significant difference in short-term mortality following RN-IVCT when stratified by hospital case volume.
CONCLUSIONS: Higher hospital case volume was associated with longer OS for patients undergoing RN-IVCT. These findings support efforts to centralize care for cases of advanced RCC. PATIENT
SUMMARY: In this study we looked at the impact of hospital case volume on survival following surgery for renal cell carcinoma and inferior vena cava thrombectomy. Survival was significantly better in high-volume hospitals performing three or more procedures per year.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hospital volume; Inferior vena cava; Nephrectomy; Renal cell carcinoma; Survival; Thrombectomy; Tumor thrombus

Mesh:

Year:  2018        PMID: 31411983      PMCID: PMC6697235          DOI: 10.1016/j.euo.2018.10.005

Source DB:  PubMed          Journal:  Eur Urol Oncol        ISSN: 2588-9311


  1 in total

1.  Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial.

Authors:  Vitaly Margulis; Yuval Freifeld; Laurentiu M Pop; Subrata Manna; Payal Kapur; Ivan Pedrosa; Alana Christie; Osama Mohamad; Samantha Mannala; Nirmish Singla; Michael Wait; Aditya Bagrodia; Solomon L Woldu; Jeffrey Gahan; James Brugarolas; Robert Timmerman; Raquibul Hannan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-02-05       Impact factor: 8.013

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.